SOX2 and neoplasm: Indeed, SOX2 itself [91], as well as its targets (including the Notch pathway, transcription factors, signaling molecules [87,93]), are actively investigated from the perspective of inactivating the SOX2-controlled gene regulatory network in CSC/TIC, as a therapeutic perspective for neural, and other tumor types [87,88,90,91,92,93].